-
Mashup Score: 6Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis - 3 hour(s) ago
FLC-MS can detect persistent light chains in a significant proportion of patients in a conventional hematologic CR.Patients with no detectable FLC by FLC-M
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 14Clonal Hematopoiesis of Indeterminate Potential in Patients with Immunoglobulin Light Chain AL Amyloidosis - 4 hour(s) ago
Key Points. CHIP is more prevalent in AL amyloidosis patients than in the general populationCHIP presence was associated with the presence of t(11;14) and
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Large language models are getting bigger and better - 3 day(s) ago
Can they keep improving forever?
Source: www.economist.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in MajesTEC-1 - 3 day(s) ago
Key Points. Better clinical responses to teclistamab correlate with a more functional initial immune T-cell repertoire in the periphery and tumor siteMore
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 37CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma - 7 day(s) ago
Teclistamab is effective in real-world patients with R/RMM, including those with prior anti-BCMA therapy exposure, albeit with slightly poorer progression-
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma - 18 day(s) ago
Teclistamab is effective in real-world patients with R/RMM, including those with prior anti-BCMA therapy exposure, albeit with slightly poorer progression-
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy - 18 day(s) ago
Key Points. Multiple myeloma patients previously treated with T-cell redirection therapy have significantly low risk of developing CRS with teclistamabPati
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Yuval Noah Harari argues that AI has hacked the operating system of human civilisation - 20 day(s) ago
Storytelling computers will change the course of human history, says the historian and philosopher
Source: www.economist.comCategories: General Medicine News, Hem/OncsTweet
Patients with no detectable FLC by mass spectrometry have significantly better OS and organ response irrespective of conventional hematologic response #mmsm #amyloidosis @JBomsztyk @awechalekar @BloodJournal https://t.co/7FLOQGfBBU